XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.4
UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income
Balance at beginning of period (in shares) at Jun. 27, 2021     115,691,000          
Balance at beginning of period at Jun. 27, 2021 $ 2,116.5   $ 0.1 $ 3,676.8   $ (1,563.1)   $ 2.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (70.1)         (70.1)    
Unrealized loss on available-for-sale securities (0.8)             (0.8)
Comprehensive loss (70.9)              
Tax withholding on vested equity awards (22.5)     (22.5)        
Stock-based compensation 15.6     15.6        
Exercise of stock options and issuance of shares (in shares)     495,000          
Exercise of stock options and issuance of shares 0.7     0.7        
Balance at end of period (in shares) at Sep. 26, 2021     116,186,000          
Balance at end of period at Sep. 26, 2021 2,039.4   $ 0.1 3,670.6   (1,633.2)   1.9
Balance at beginning of period (in shares) at Jun. 27, 2021     115,691,000          
Balance at beginning of period at Jun. 27, 2021 2,116.5   $ 0.1 3,676.8   (1,563.1)   2.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (166.8)              
Unrealized loss on available-for-sale securities (4.4)              
Comprehensive loss (171.2)              
Balance at end of period (in shares) at Dec. 26, 2021     123,570,000          
Balance at end of period at Dec. 26, 2021 2,378.9   $ 0.2 4,110.3   (1,729.9)   (1.7)
Balance at beginning of period (in shares) at Jun. 27, 2021     115,691,000          
Balance at beginning of period at Jun. 27, 2021 $ 2,116.5   $ 0.1 3,676.8   (1,563.1)   2.7
Balance at end of period (in shares) at Jun. 26, 2022 123,795,000   123,795,000          
Balance at end of period at Jun. 26, 2022 $ 2,439.3 $ (303.3) $ 0.2 4,228.4 $ (333.0) (1,764.0) $ 29.7 (25.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Adoption of ASU 2020-06 [Extensible Enumeration] Adoption of ASU 2020-06              
Balance at beginning of period (in shares) at Sep. 26, 2021     116,186,000          
Balance at beginning of period at Sep. 26, 2021 $ 2,039.4   $ 0.1 3,670.6   (1,633.2)   1.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (96.7)         (96.7)    
Unrealized loss on available-for-sale securities (3.6)             (3.6)
Comprehensive loss (100.3)              
Tax withholding on vested equity awards (2.8)     (2.8)        
Stock-based compensation 15.7     15.7        
Exercise of stock options and issuance of shares (in shares)     258,000          
Exercise of stock options and issuance of shares 10.7     10.7        
Issuance of shares related to the extinguishment of convertible notes due September 1, 2023 (in shares)     7,126,000          
Issuance of shares related to the extinguishment of convertible notes due September 1, 2023 416.2   $ 0.1 416.1        
Balance at end of period (in shares) at Dec. 26, 2021     123,570,000          
Balance at end of period at Dec. 26, 2021 $ 2,378.9   $ 0.2 4,110.3   (1,729.9)   (1.7)
Balance at beginning of period (in shares) at Jun. 26, 2022 123,795,000   123,795,000          
Balance at beginning of period at Jun. 26, 2022 $ 2,439.3 (303.3) $ 0.2 4,228.4 (333.0) (1,764.0) 29.7 (25.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (26.2)         (26.2)    
Unrealized loss on available-for-sale securities (7.0)             (7.0)
Comprehensive loss (33.2)              
Tax withholding on vested equity awards (16.9)     (16.9)        
Stock-based compensation 23.2     23.2        
Exercise of stock options and issuance of shares (in shares)     415,000          
Exercise of stock options and issuance of shares 0.5     0.5        
Balance at end of period (in shares) at Sep. 25, 2022     124,210,000          
Balance at end of period at Sep. 25, 2022 $ 2,109.6   $ 0.2 3,902.2   (1,760.5)   (32.3)
Balance at beginning of period (in shares) at Jun. 26, 2022 123,795,000   123,795,000          
Balance at beginning of period at Jun. 26, 2022 $ 2,439.3 $ (303.3) $ 0.2 4,228.4 $ (333.0) (1,764.0) $ 29.7 (25.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (117.1)              
Unrealized loss on available-for-sale securities (3.3)              
Comprehensive loss $ (120.4)              
Balance at end of period (in shares) at Dec. 25, 2022 124,413,000   124,413,000          
Balance at end of period at Dec. 25, 2022 $ 1,780.2   $ 0.2 3,660.0   (1,851.4)   (28.6)
Balance at beginning of period (in shares) at Sep. 25, 2022     124,210,000          
Balance at beginning of period at Sep. 25, 2022 2,109.6   $ 0.2 3,902.2   (1,760.5)   (32.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (90.9)         (90.9)    
Unrealized loss on available-for-sale securities 3.7             3.7
Comprehensive loss (87.2)              
Tax withholding on vested equity awards (0.4)     (0.4)        
Stock-based compensation 21.4     21.4        
Exercise of stock options and issuance of shares (in shares)     203,000          
Exercise of stock options and issuance of shares 10.7     10.7        
Capped call transactions related to the issuance of convertible notes due December 1, 2029 $ (273.9)     (273.9)        
Balance at end of period (in shares) at Dec. 25, 2022 124,413,000   124,413,000          
Balance at end of period at Dec. 25, 2022 $ 1,780.2   $ 0.2 $ 3,660.0   $ (1,851.4)   $ (28.6)